Sight Sciences, Inc. (SGHT)

Sight Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	138.13	185	260.69	61.51	21.24
Cash & Cash Equivalents	138.13	185	260.69	61.51	21.24
Cash Growth	-25.34%	-29.03%	323.81%	189.64%	400.64%
Receivables	14.29	15.15	8.71	5.36	4.09
Inventory	7.85	6.11	3.48	2.6	2.24
Other Current Assets	2.6	3.42	4.16	1.16	0.43
Total Current Assets	162.87	209.68	277.04	70.63	28
Property, Plant & Equipment	3.1	3.19	2.95	1.79	2.57
Other Long-Term Assets	0.68	0.21	0.2	0.39	0.17
Total Long-Term Assets	3.78	3.4	3.15	2.17	2.74
Total Assets	166.65	213.07	280.19	72.81	30.74
Accounts Payable	1.73	2.69	3.35	2.16	2.32
Current Debt	2.22	0	0	0	0
Other Current Liabilities	8.3	15.13	10.15	7.16	5.02
Total Current Liabilities	12.25	17.82	13.5	9.31	7.34
Long-Term Debt	31.71	33.31	32.66	31.96	12.86
Other Long-Term Liabilities	2.48	1.87	1.92	3.06	0.98
Total Long-Term Liabilities	34.18	35.18	34.58	35.01	13.83
Total Liabilities	46.44	53	48.08	44.32	21.17
Total Debt	33.93	33.31	32.66	31.96	12.86
Debt Growth	1.84%	2.01%	2.19%	148.58%	-
Retained Earnings	-294.79	-239.24	-153	-90.04	-55.35
Shareholders' Equity	120.22	160.08	232.11	-88.85	-54.68
Net Cash / Debt	104.2	151.69	228.03	29.56	8.38
Net Cash / Debt Growth	-31.30%	-33.48%	671.52%	252.61%	97.60%
Net Cash Per Share	2.14	3.17	8.53	3.16	0.89
Working Capital	150.62	191.86	263.53	61.32	20.67
Book Value Per Share	2.47	3.35	8.68	-9.50	-5.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).